Literature DB >> 16364029

Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.

Baki Akgül1, Regina Pfefferle, Gian Paolo Marcuzzi, Paola Zigrino, Thomas Krieg, Herbert Pfister, Cornelia Mauch.   

Abstract

Human papillomaviruses (HPV) are small DNA viruses that induce a wide variety of hyperproliferative lesions in cutaneous and mucosal epithelia. It is proposed that HPV is involved in non-melanoma skin cancer development. We have previously shown that HPV8 transgenic mice spontaneously develop papillomatous skin tumors. Histology revealed epidermal hyperplasia, acanthosis and hypergranulosis and in some cases squamous cell carcinomas (SCC). Zymographic and immunoblot analysis of normal skin extracts identified increased amounts of matrix metalloproteinase (MMP)-9, MMP-13 and MT1-MMP in HPV8-positive mice compared with HPV8-negative animals. In situ gelatin zymography of tumor specimens displayed a strong proteolytic activity in papillomas, and SCC putatively attributed to the increased amounts of activated MMP-9 found in tissue extracts. In addition, immunoblot analysis revealed increased amounts of active MMP-13 and MT1-MMP in tumor extracts as compared with control extracts. Immunohistochemical stainings of SCC specimens depicted MMP-13 to be specifically expressed in stromal fibroblasts neighboring the tumor islands, whereas MT1-MMP was detected both in tumor cells and in stromal cells. Taken together, these results implicate a role for MMPs in the development of HPV8-induced cutaneous tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16364029     DOI: 10.1111/j.0906-6705.2005.00387.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  18 in total

1.  The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.

Authors:  Baki Akgül; Ramón García-Escudero; Christine Ekechi; Gertrud Steger; Harshad Navsaria; Herbert Pfister; Alan Storey
Journal:  Med Microbiol Immunol       Date:  2011-01-28       Impact factor: 3.402

Review 2.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

3.  Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins.

Authors:  Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

4.  Nuclear export of cutaneous HPV8 E7 oncoprotein is mediated by a leucine-rich nuclear export signal via a CRM1 pathway.

Authors:  Zeynep Onder; Vivian Chang; Junona Moroianu
Journal:  Virology       Date:  2014-11-09       Impact factor: 3.616

5.  Mechanical stretching modulates growth direction and MMP-9 release in human keratinocyte monolayer.

Authors:  Filippo Renò; Vincenzina Traina; Mario Cannas
Journal:  Cell Adh Migr       Date:  2009-07-01       Impact factor: 3.405

Review 6.  [HPV and skin neoplasia].

Authors:  H Pfister
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

Review 7.  Recent advances in preclinical model systems for papillomaviruses.

Authors:  Neil D Christensen; Lynn R Budgeon; Nancy M Cladel; Jiafen Hu
Journal:  Virus Res       Date:  2016-12-09       Impact factor: 3.303

Review 8.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

9.  Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.

Authors:  H Fukuda; S Mochizuki; H Abe; H J Okano; C Hara-Miyauchi; H Okano; N Yamaguchi; M Nakayama; J D'Armiento; Y Okada
Journal:  Br J Cancer       Date:  2011-10-20       Impact factor: 7.640

10.  Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis.

Authors:  Sven Reischauer; Mitchell P Levesque; Christiane Nüsslein-Volhard; Mahendra Sonawane
Journal:  PLoS Genet       Date:  2009-11-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.